Global Pet Speciality Drugs Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Pet Speciality Drugs Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Antibiotics
- 1.2.3 Anti-inflammatory Drugs
- 1.2.4 Vaccines
- 1.2.5 Parasiticides
- 1.2.6 Skin Care Products
- 1.2.7 Others
- 1.3 Market by Application
- 1.3.1 Global Pet Speciality Drugs Market Share by Application: 2020 VS 2026
- 1.3.2 Dogs
- 1.3.3 Cats
- 1.3.4 Other
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Pet Speciality Drugs Market Perspective (2015-2026)
- 2.2 Global Pet Speciality Drugs Growth Trends by Regions
- 2.2.1 Pet Speciality Drugs Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Pet Speciality Drugs Historic Market Share by Regions (2015-2020)
- 2.2.3 Pet Speciality Drugs Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Pet Speciality Drugs Players by Market Size
- 3.1.1 Global Top Pet Speciality Drugs Players by Revenue (2015-2020)
- 3.1.2 Global Pet Speciality Drugs Revenue Market Share by Players (2015-2020)
- 3.2 Global Pet Speciality Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Pet Speciality Drugs Revenue
- 3.4 Global Pet Speciality Drugs Market Concentration Ratio
- 3.4.1 Global Pet Speciality Drugs Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Pet Speciality Drugs Revenue in 2019
- 3.5 Key Players Pet Speciality Drugs Area Served
- 3.6 Key Players Pet Speciality Drugs Product Solution and Service
- 3.7 Date of Enter into Pet Speciality Drugs Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Speciality Drugs Breakdown Data by Type (2015-2026)
- 4.1 Global Pet Speciality Drugs Historic Market Size by Type (2015-2020)
- 4.2 Global Pet Speciality Drugs Forecasted Market Size by Type (2021-2026)
5 Pet Speciality Drugs Breakdown Data by Application (2015-2026)
- 5.1 Global Pet Speciality Drugs Historic Market Size by Application (2015-2020)
- 5.2 Global Pet Speciality Drugs Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Pet Speciality Drugs Market Size (2015-2026)
- 6.2 North America Pet Speciality Drugs Market Size by Type (2015-2020)
- 6.3 North America Pet Speciality Drugs Market Size by Application (2015-2020)
- 6.4 North America Pet Speciality Drugs Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Pet Speciality Drugs Market Size (2015-2026)
- 7.2 Europe Pet Speciality Drugs Market Size by Type (2015-2020)
- 7.3 Europe Pet Speciality Drugs Market Size by Application (2015-2020)
- 7.4 Europe Pet Speciality Drugs Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Pet Speciality Drugs Market Size (2015-2026)
- 8.2 China Pet Speciality Drugs Market Size by Type (2015-2020)
- 8.3 China Pet Speciality Drugs Market Size by Application (2015-2020)
- 8.4 China Pet Speciality Drugs Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Pet Speciality Drugs Market Size (2015-2026)
- 9.2 Japan Pet Speciality Drugs Market Size by Type (2015-2020)
- 9.3 Japan Pet Speciality Drugs Market Size by Application (2015-2020)
- 9.4 Japan Pet Speciality Drugs Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Pet Speciality Drugs Market Size (2015-2026)
- 10.2 Southeast Asia Pet Speciality Drugs Market Size by Type (2015-2020)
- 10.3 Southeast Asia Pet Speciality Drugs Market Size by Application (2015-2020)
- 10.4 Southeast Asia Pet Speciality Drugs Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11Key Players Profiles
- 11.1 Zoetis
- 11.1.1 Zoetis Company Details
- 11.1.2 Zoetis Business Overview
- 11.1.3 Zoetis Pet Speciality Drugs Introduction
- 11.1.4 Zoetis Revenue in Pet Speciality Drugs Business (2015-2020))
- 11.1.5 Zoetis Recent Development
- 11.2 Merck
- 11.2.1 Merck Company Details
- 11.2.2 Merck Business Overview
- 11.2.3 Merck Pet Speciality Drugs Introduction
- 11.2.4 Merck Revenue in Pet Speciality Drugs Business (2015-2020)
- 11.2.5 Merck Recent Development
- 11.3 Bayer
- 11.3.1 Bayer Company Details
- 11.3.2 Bayer Business Overview
- 11.3.3 Bayer Pet Speciality Drugs Introduction
- 11.3.4 Bayer Revenue in Pet Speciality Drugs Business (2015-2020)
- 11.3.5 Bayer Recent Development
- 11.4 Elanco
- 11.4.1 Elanco Company Details
- 11.4.2 Elanco Business Overview
- 11.4.3 Elanco Pet Speciality Drugs Introduction
- 11.4.4 Elanco Revenue in Pet Speciality Drugs Business (2015-2020)
- 11.4.5 Elanco Recent Development
- 11.5 Boehringer Ingelheim
- 11.5.1 Boehringer Ingelheim Company Details
- 11.5.2 Boehringer Ingelheim Business Overview
- 11.5.3 Boehringer Ingelheim Pet Speciality Drugs Introduction
- 11.5.4 Boehringer Ingelheim Revenue in Pet Speciality Drugs Business (2015-2020)
- 11.5.5 Boehringer Ingelheim Recent Development
- 11.6 Ceva Sante Animale
- 11.6.1 Ceva Sante Animale Company Details
- 11.6.2 Ceva Sante Animale Business Overview
- 11.6.3 Ceva Sante Animale Pet Speciality Drugs Introduction
- 11.6.4 Ceva Sante Animale Revenue in Pet Speciality Drugs Business (2015-2020)
- 11.6.5 Ceva Sante Animale Recent Development
- 11.7 Vetoquinol
- 11.7.1 Vetoquinol Company Details
- 11.7.2 Vetoquinol Business Overview
- 11.7.3 Vetoquinol Pet Speciality Drugs Introduction
- 11.7.4 Vetoquinol Revenue in Pet Speciality Drugs Business (2015-2020)
- 11.7.5 Vetoquinol Recent Development
- 11.8 Virbac
- 11.8.1 Virbac Company Details
- 11.8.2 Virbac Business Overview
- 11.8.3 Virbac Pet Speciality Drugs Introduction
- 11.8.4 Virbac Revenue in Pet Speciality Drugs Business (2015-2020)
- 11.8.5 Virbac Recent Development
- 11.9 Wedgewood Pharmacy
- 11.9.1 Wedgewood Pharmacy Company Details
- 11.9.2 Wedgewood Pharmacy Business Overview
- 11.9.3 Wedgewood Pharmacy Pet Speciality Drugs Introduction
- 11.9.4 Wedgewood Pharmacy Revenue in Pet Speciality Drugs Business (2015-2020)
- 11.9.5 Wedgewood Pharmacy Recent Development
- 11.10 Lee Silsby Compounding Pharmacy
- 11.10.1 Lee Silsby Compounding Pharmacy Company Details
- 11.10.2 Lee Silsby Compounding Pharmacy Business Overview
- 11.10.3 Lee Silsby Compounding Pharmacy Pet Speciality Drugs Introduction
- 11.10.4 Lee Silsby Compounding Pharmacy Revenue in Pet Speciality Drugs Business (2015-2020)
- 11.10.5 Lee Silsby Compounding Pharmacy Recent Development
- 11.11 Golden Gate Veterinary Compounding Pharmacy
- 10.11.1 Golden Gate Veterinary Compounding Pharmacy Company Details
- 10.11.2 Golden Gate Veterinary Compounding Pharmacy Business Overview
- 10.11.3 Golden Gate Veterinary Compounding Pharmacy Pet Speciality Drugs Introduction
- 10.11.4 Golden Gate Veterinary Compounding Pharmacy Revenue in Pet Speciality Drugs Business (2015-2020)
- 10.11.5 Golden Gate Veterinary Compounding Pharmacy Recent Development
- 11.12 CAHIC
- 10.12.1 CAHIC Company Details
- 10.12.2 CAHIC Business Overview
- 10.12.3 CAHIC Pet Speciality Drugs Introduction
- 10.12.4 CAHIC Revenue in Pet Speciality Drugs Business (2015-2020)
- 10.12.5 CAHIC Recent Development
- 11.13 Ringpu
- 10.13.1 Ringpu Company Details
- 10.13.2 Ringpu Business Overview
- 10.13.3 Ringpu Pet Speciality Drugs Introduction
- 10.13.4 Ringpu Revenue in Pet Speciality Drugs Business (2015-2020)
- 10.13.5 Ringpu Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Pet Speciality Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pet Speciality Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Antibiotics
Anti-inflammatory Drugs
Vaccines
Parasiticides
Skin Care Products
Others
Market segment by Application, split into
Dogs
Cats
Other
Based on regional and country-level analysis, the Pet Speciality Drugs market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Pet Speciality Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Zoetis
Merck
Bayer
Elanco
Boehringer Ingelheim
Ceva Sante Animale
Vetoquinol
Virbac
Wedgewood Pharmacy
Lee Silsby Compounding Pharmacy
Golden Gate Veterinary Compounding Pharmacy
CAHIC